Bioventus (BVS) Retained Earnings (2021 - 2026)
Bioventus (BVS) posted Retained Earnings of $522.9 million for Q1 2026, up 256.13% on a QoQ basis from -$334.9 million in Q4 2025, and up 25459.46% year-over-year from N/an in Q1 2025.
Bioventus (BVS) Retained Earnings (2021 - 2026) Analysis & Trends
Bioventus' Retained Earnings history runs 6 years deep, the most recent figure standing at $522.9 million for Q1 2026.
- Quarterly Retained Earnings rose 25459.46% year-over-year to $522.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $522.9 million (up 25459.46% YoY) and the FY2025 annual result came in at -$334.9 million, up 6.36% from the prior year.
- Retained Earnings was $522.9 million for Q1 2026 at Bioventus, up from -$334.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $522.9 million in Q1 2026 and bottomed at -$357.7 million in Q4 2024.
- A 5-year average of -$11.4 million and a median of -$1.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 101138.46% — and 2023, when it sank 83772.18%.
- Bioventus' Retained Earnings stood at -$165.3 million in 2022, then surged by 398.99% to $494.3 million in 2023, then tumbled by 172.36% to -$357.7 million in 2024, then rose by 6.36% to -$334.9 million in 2025, then surged by 256.13% to $522.9 million in 2026.
- Business Quant data shows BVS's Retained Earnings at $522.9 million in Q1 2026, -$334.9 million in Q4 2025, and -$349.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 2.63 Bn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | -1.40 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | - |
| 10 | Bioventus | 826.57 Mn | 790.72 Mn | 90.77 Mn | 522.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 522.91 Mn |
| Dec 31, 2025 | -334.93 Mn |
| Sep 27, 2025 | -349.68 Mn |
| Jun 28, 2025 | -774,000.00 |
| Mar 29, 2025 | -2.06 Mn |
| Dec 31, 2024 | -357.66 Mn |
| Sep 28, 2024 | -354.92 Mn |
| Jun 29, 2024 | 500.97 Mn |
| Mar 30, 2024 | 325,000.00 |
| Dec 31, 2023 | 494.25 Mn |
| Sep 30, 2023 | -315.44 Mn |
| Jul 1, 2023 | 655,000.00 |
| Apr 1, 2023 | -304.46 Mn |
| Dec 31, 2022 | -165.31 Mn |
| Oct 1, 2022 | -1.34 Mn |
| Jul 2, 2022 | 473.80 Mn |
| Apr 2, 2022 | -363,000.00 |
| Dec 31, 2021 | 473.32 Mn |
| Oct 2, 2021 | 158.48 Mn |
| Jul 3, 2021 | 468,000.00 |